Updated:
IMO Ventures
IMO Ventures is a seed investor based in China and the U.S. It has made 93 investments, including a September 16, 2025, investment in Hopewell Therapeutics.
IMO Ventures
IMO Ventures is a seed investor based in China and the U.S. It has made 93 investments, including a September 16, 2025, investment in Hopewell Therapeutics. The firm has 2 portfolio exits, with XtalPi exiting on June 13, 2024.
General information
Firm type
Venture Capital
Year founded
2016
Location
Region
Asia
Country
China
City
Shenzhen
Corporate office
Shenzhen, China
Frequently asked questions
How does IMO Ventures source its deal flow?
IMO Ventures sources primarily through the Shenzhen hardware and manufacturing ecosystem. Founders building physical products typically enter IMO's orbit when they seek production partners in the Pearl River Delta — the firm's supply-chain network generates proprietary referrals that generalist VCs do not see. The firm also maintains relationships with Western accelerators and university spinouts that require Asia-based manufacturing support.
Does IMO Ventures invest only in Chinese startups?
No. IMO's model is explicitly cross-border: portfolio companies are often incorporated in the United States or Europe, with design and go-to-market teams based in those regions, while manufacturing and hardware engineering occur in Shenzhen. The firm selects for startups that can exploit this geographic arbitrage rather than companies serving only the domestic Chinese market.
What investment stages does IMO Ventures target?
IMO focuses on early-stage venture rounds — seed and Series A — where companies have validated a product concept but require capital and operational support to reach production scale. The firm does not publicly disclose participation in later-stage growth rounds, suggesting a concentrated early-entry strategy tied to its manufacturing value-add.
What types of companies does IMO Ventures explicitly avoid?
IMO's operational model constrains its investable universe to businesses where physical supply-chain and manufacturing density provide a competitive edge. Pure software, enterprise SaaS without hardware components, and capital-light service businesses fall outside the firm's structural advantage and are not known targets. The firm is also unlikely to back companies that manufacture entirely outside the Shenzhen industrial corridor.
How is IMO Ventures structured as a firm?
IMO operates as a venture capital asset manager headquartered in Shenzhen. The firm has not publicly disclosed its fund structure, limited partner base, or regulatory registration details. Available public records do not indicate whether IMO manages commingled funds, separate accounts, or a single investment vehicle.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on venture capital firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: